ShareValue scores for VME.XETRA: Valuation 61, Quality 48, Growth 50, Health 48.
VME.XETRAXETRA
VIROMED MEDICAL NA O.N.
€7.70
(0.00%)
VME.XETRAXETRA
VIROMED MEDICAL NA O.N.
€7.70(0.00%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
7% to 17%
Rating
Trap Risk
Return
7% to 17%
Valuation
61
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
45
Neutral
Price Trend
Company Details
About
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.
Market Cap$164M
P/E Ratio258.3
Dividend YieldNone
Sector Rank#1155
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026